THE PAN-MASS CHALLENGE announced a gift of $45 million to support adult and pediatric patient care and cancer research at Dana-Farber Cancer Institute, bringing the PMC’s 36-year fundraising total to a half-billion dollars raised since the organization’s inception in 1980.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
